Adalimumab Improves Blood Parameters in Patients With HS

TOPLINE: Treatment with adalimumab improves anemia, thrombocytosis, and leukocytosis in patients with hidradenitis suppurativa (HS), in clinical responders and nonresponders. METHODOLOGY: HS is a chronic inflammatory skin condition characterized by a high inflammatory burden and hematologic abnormalities such as anemia, leukocytosis, and thrombocytosis. Immunomodulatory therapy was previously found to improve hematologic abnormalities in a small ...

https://teach.coursemateai.com/home/course/get-it-done/163 
Get In Touch

Cape Breton, NS

+012 345 67890

Chris@websurfer.ca

Follow Us
Flickr Photos

Copyright © 2023 cape-breton.com. Toady's News. All Rights Reserved